Sign in

Trial result ·

Early exercise therapy for acute nephrotic syndrome: a randomised clinical trial.

Written based on 1 research study on PubMed, searched on 15 Nov 2026.

What was studied

This study looked at adults in hospital with acute nephrotic syndrome. All were taking glucocorticoid drugs for this kidney disease. People were put by chance in an exercise group or a usual care group. The trial took place at one hospital. 13 people did early exercise, and 14 had usual care. The main test was how much oxygen the body could use at peak effort. The team also checked if the kidney disease went into remission by 6 weeks.

What they found

In the exercise group, peak oxygen use went up by 3.45 mL/kg/min. The authors call this rise significant. In the usual care group, it rose by 1.00 mL/kg/min. That rise was not significant. After 6 weeks, the gap between the groups was 2.46 mL/kg/min. But this gap was not large enough to be sure it was real. The risk of the disease not going into remission did not differ clearly between groups.

What it means for patients

The authors say early exercise helped people handle exercise better. They judged this gain useful in care. Still, the main gap between the groups was not proven. They found no sign that exercise raised the risk of no remission.

Why it is not certain yet

Only 13 and 14 people took part in the groups. The trial was done at one hospital. The main gap between groups was not statistically significant. Follow-up lasted 6 weeks, so later effects are not known. Some data were missing and had to be filled in by math. The abstract does not describe other harms from exercise.

Source

Early exercise therapy for acute nephrotic syndrome: a randomised clinical trial.

PubMed · PMID 42584019

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Nephrotic syndrome publications